Navigation Links
Mylan Receives Approval for Generic Version of Neurontin® Tablets
Date:6/4/2010

PITTSBURGH, June 4 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Gabapentin Tablets USP, 600 mg and 800 mg, the generic version of Pfizer's Neurontin® Tablets for the treatment of postherpetic neuralgia, a complication of shingles. The product will be distributed by Mylan Pharmaceuticals Inc.

Gabapentin Tablets had U.S. sales of approximately $174 million for the 12 months ending March 31, 2010, according to IMS Health.

Currently, Mylan has 140 ANDAs pending FDA approval representing $95.5 billion in annual brand sales, according to IMS Health. Forty of these pending ANDAs are potential first-to-file opportunities, representing 21 billion in annual brand sales, for the 12 months ending Dec. 31, 2009 according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information, please visit www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Receives Approval for Generic Version of Valtrex®
2. Mylan Launches Temazepam Capsules USP, 7.5 mg
3. Mylan Announces Completion of Senior Notes Offering
4. Mylan Announces Upsizing and Pricing of Senior Notes
5. Mylan Announces Proposed Senior Notes Private Placement
6. Mylan Receives Approval for Generic Version of Zyban(R)
7. Mylan Receives Approval for Generic Version of Flomax(R)
8. Mylan Schedules First Quarter 2010 Financial Results Conference Call and Live Webcast
9. Mylan Receives Approval for Generic Version of Actigall(R)
10. Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility
11. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... Longer life expectancy and rising healthcare expenditure in developing countries ... technologies. BCC Research reveals in its new report that markets ... should see strong growth due to rising government healthcare spending, increased levels ... Continue Reading ... ...
(Date:1/23/2017)... Spain , January 23, 2017 ... clinical-stage biopharmaceutical company focused on treatments for calcification ... been enrolled in the Phase IIb "CaLIPSO Study" ... treatment of cardiovascular calcification (CVC) in end-stage-renal-disease (ESRD) ... patients, in the last stage of chronic kidney ...
(Date:1/22/2017)... DHABI , Saudi Arabia , January 22, 2017 /PRNewswire/ ... the US and UAE ... , at the World Economic Forum   "The ... driven by big data and powered by artificial intelligence and this trend is ... discussed the ,Hospital of the Future, at the concluding day of the 47 ...
Breaking Medicine Technology:
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... “Crossing the ... last ten minutes of a woman’s life. “Crossing the Bar” is the creation of ... of three children. , Charlotte, who credits the inspiration of the book to ...
(Date:1/23/2017)... ... ... Under Blankets”: an entrancing story about one woman's travels through the wilderness of ... published author, Kimberly Mitchell, who earned her bachelor’s degree in English education at the ... degree in education in the field of curriculum and instruction. Kimberly’s passion for writing ...
(Date:1/23/2017)... ... 2017 , ... Valentine’s Day is a time when many people celebrate romance and love by ... be looking for the ideal present, Atlanta-based Perimeter Plastic Surgery is offering a ... Or, spend $200 and get $50 free. , “A lot of people just buy ...
(Date:1/22/2017)... ... January 22, 2017 , ... Zifam Pinnacle, an Australian ... world, recently met with big-name retail buyers at the January ECRM Trade Show in ... and uses the utmost safety standards in all of its creations to help create ...
(Date:1/22/2017)... ... ... Medical lab testing through hospitals and other traditional methods can be ... days to arrive to the end customer, having to travel through medical records and ... bypassing the cost and delay of traditional means. Now all employees of the Frisco ...
Breaking Medicine News(10 mins):